Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease

Por Wang, Ming-Hsi, Friton, Jessica J, Raffals, Laura E, Leighton, Jonathan A, Pasha, Shabana F, Picco, Michael F, Cushing, Kelly C, Monroe, Kelly, Nix, Billy D, Newberry, Rodney D, Faubion, William A
Publicado no J Crohns Colitis (2019)

The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)

Por Sarmento, Olga F., Svingen, Phyllis A., Xiong, Yuning, Sun, Zhifu, Bamidele, Adebowale O., Mathison, Angela J., Smyrk, Thomas C., Nair, Asha A., Gonzalez, Michelle M., Sagstetter, Mary R., Baheti, Saurabh, McGovern, Dermot P. B., Friton, Jessica J., Papadakis, Konstantinos A., Gautam, Goel, Xavier, Ramnik J., Urrutia, Raul A., Faubion, William A.
Publicado no J Biol Chem (2017)